TSXV:BTI.H - Post by User
Comment by
prophetoffactzon Feb 24, 2023 2:29pm
51 Views
Post# 35304030
RE:Midatech Share Price Is Dropping
RE:Midatech Share Price Is Dropping"Midatech's share price has been dropping from 76.5¢ on February 9th, the day that Midatech announced its new financing at an initial proice of 58¢ per unit. As I write this, the Midatech share price is down 33% to 50.8¢."
The S&P Biotech ETF began dropping around the same time. Since Feb 2 it is down about 11.2%. That's a big drop for an index with advanced companies. Preclinical is a real hell hole during an inflation scare. xB3 may be 2 years from the clinic and a proof in humans let alone revenue. That's why Rathjen has tried to add Phase II ready assets like Cresence and when that wasn't enough Biodexa. Biodexa would have had enough cash to get to hard data with the Armistice financing. Midatech needs to produce a proof in humans for glioblastoma and get closer to revenue.